CLINICAL HANDBOOK OF SCHIZOPHRENIA

410 VI. SPECIAL POPULATIONS AND PROBLEMSREFERENCES AND RECOMMENDED READINGSDay, J., Wood, G., Dewey, M., & Bentall, R. P. (1995). A self-rating scale for measuring neurolepticside effects: Validation in a group of schizophrenic patients. British Journal of Psychiatry,167(1), 113–114.Haddock, G., Lowens, I., Barrowclough, C., Brosnan, N., Lowens, I., & Novaco, R. (2004). Cognitive-behaviourtherapy for inpatients with psychosis and anger problems within a low secure environment.Behavioural and Cognitive Psychotherapy, 32, 77–98.Haddock, G., McCarron, J., Tarrier, N., & Faragher, E. B. (1999). Scales to measure dimensions ofhallucinations and delusions: The Psychotic Symptom Rating Scales (PSYRATS). PsychologicalMedicine, 29, 879–889.Hogan, T. P., Awad, A. G., & Eastwood, R. (1983). A self-report scale of drug compliance in schizophrenia:Reliability and discriminative validity. Psychological Medicine, 13(1), 177–183.Kay, S. R., Opler, L. A., & Lindenmayer, J. P. (1989). The Positive and Negative Syndrome Scale(PANSS): Rationale and standardization. British Journal of Psychiatry, 155, 59–65.Leucht, S., Barnes, T. R. E., Kissling, W., Engel, R. R., Correll, C., & Kane, J. M. (2003). Relapse preventionin schizophrenia with new-Generation antipsychotics: A systematic review and exploratorymeta-analysis of randomized, controlled trials. American Journal of Psychiatry, 160(7),1209–1222.Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nded.). New York: Guilford Press.Mueser, K. T., Crocker, A. G., Frisman, L. B., Drake, R. E., Covell, N. H., & Essock, S. M. (2006).Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substanceuse disorders. Schizophrenia Bulletin, 32(4), 626–636.National Institute for Clinical Excellence. (2002). Schizophrenia core interventions in the treatmentand management of schizophrenia in primary and secondary care. London: Author.Novaco, R. W. (2003). Novaco Anger Scale and Provocation Inventory. Los Angeles: Western PsychologicalAssociation.Novaco, R. W. (1994). Anger as a risk factor for violence among the mentally disordered. In J.Monahan & H. Steadman (Eds.), Violence and mental disorder: Developments in risk assessment.Chicago: University of Chicago Press.Swanson, J. W. (2004). Effectiveness of atypical antipsychotic medications in reducing violent behaviouramong persons with schizophrenia in community-based treatment. Schizophrenia Bulletin,30, 3–20.Tarrier, N., Wells, A., & Haddock, G. (1998). Treating complex cases: A cognitive behavioral approach.Chichester, UK: Wiley.